Cargando…
Splice-switching of the insulin receptor pre-mRNA alleviates tumorigenic hallmarks in rhabdomyosarcoma
Rhabdomyosarcoma (RMS) is an aggressive pediatric tumor with a poor prognosis for metastasis and recurrent disease. Large-scale sequencing endeavors demonstrate that Rhabdomyosarcomas have a dearth of precisely targetable driver mutations. However, IGF-2 signaling is known to be grossly altered in R...
Autores principales: | Khurshid, Safiya, Montes, Matias, Comiskey, Daniel F., Shane, Brianne, Matsa, Eleftheria, Jung, Francesca, Brown, Chelsea, Bid, Hemant Kumar, Wang, Ruoning, Houghton, Peter J., Roberts, Ryan, Rigo, Frank, Chandler, Dawn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752779/ https://www.ncbi.nlm.nih.gov/pubmed/35017650 http://dx.doi.org/10.1038/s41698-021-00245-5 |
Ejemplares similares
-
A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo
por: Comiskey, Daniel F., et al.
Publicado: (2017) -
Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage
por: Comiskey, Daniel F., et al.
Publicado: (2015) -
Targeting Angiogenesis in Childhood Sarcomas
por: Bid, Hemant K., et al.
Publicado: (2011) -
c-Myb regulates tumorigenic potential of embryonal rhabdomyosarcoma cells
por: Kaspar, Petr, et al.
Publicado: (2019) -
Aberrant Alternative Splicing Is Another Hallmark of Cancer
por: Ladomery, Michael
Publicado: (2013)